Back to Dashboard
VTRS · Healthcare

VIATRIS INC

USA Healthcare Filing: 2023-12-31
Smart-money confidence · 1 of 3 sources firing
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
56
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. VIATRIS INC is not currently in our model portfolio, but 10 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$20.2B
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NasdaqGS
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and…
10
Investors
1
New positions
5
Increasing
3
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Greenlight Capital (Einhorn)
Trust weight: 1.3×
New position
% of portfolio
1.8%
Position change
NEW
1.8% of Greenlight Capital's portfolio
Davis Selected Advisers
Trust weight: 1.1×
Increased +13%
% of portfolio
4.4%
Position change
+13%
4.4% of Davis Selected Advisers's portfolio
Glenview Capital Mgmt (Robbins)
Trust weight: 1.2×
Increased +34%
% of portfolio
2.9%
Position change
+34%
2.9% of Glenview Capital Mgmt's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Increased +6%
% of portfolio
0.2%
Position change
+6%
0.2% of Gotham Asset Mgmt's portfolio
AQR Capital Management
Trust weight: 1.0×
Increased +28%
% of portfolio
0.0%
Position change
+28%
0.0% of AQR Capital Management's portfolio
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
Increased +201%
% of portfolio
0.0%
Position change
+201%
0.0% of Tudor Investment's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −21%
% of portfolio
0.1%
Position change
−21%
0.1% of Citadel Advisors's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Decreased −6%
% of portfolio
0.1%
Position change
−6%
0.1% of Bridgewater Associates's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Unchanged
% of portfolio
0.1%
Position change
—
0.1% of D.E. Shaw & Co's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Decreased −11%
% of portfolio
0.1%
Position change
−11%
0.1% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to VIATRIS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell VIATRIS INC or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API